甲状腺和抑郁症:从一个回顾真实世界的临床队列的见解
Ritika Baweja1, Caroline Eisele2, Mason T Breitzig1
1Department of Psychiatry and Behavioral Health, Penn State College of Medicine and Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.
Psychoneuroendocrinology
|March 13, 2026
概括
低和高的甲状腺刺激激素 (TSH) 水平与临床相关的抑郁症 (CRD) 有关. 这种联系,特别是在女性中,表明TSH可能有助于识别患有抑郁症风险的患者.
科学领域:
- 内分泌学 在内分泌学.
- 精神病学是一个精神病学.
- 临床医学 临床医学
背景情况:
- 甲状腺功能障碍是很常见的,可以呈现精神症状.
- 甲状腺刺激激素 (TSH) 水平与抑郁症之间的关系需要在临床环境中进一步研究.
研究的目的:
- 在精神病患者中调查甲状腺刺激激素 (TSH) 水平与临床相关抑郁症 (CRD) 之间的关联.
主要方法:
- 分析了来自精神病诊所的1467名成年患者队列,这些患者具有可用的TSH和PHQ-9分数.
- 后勤回归模型检查了TSH类别 (低,正常,高) 和CRD (PHQ-9分数≥10) 之间的关系,并进行了子组分析.
主要成果:
- 55%的患者患有CRD. 低TSH (OR 2.50) 和高TSH (OR 1.69) 都与CRD的几率增加有关,相比正常TSH.
- 观察到一个U形的关联,在女性中特别明显. 特定的抑郁症症状显示出与甲状腺功能的差异联系.
结论:
- 临床相关的抑郁症与低水平和高水平的TSH有关,而不考虑其他因素.
- 血清TSH水平可能有助于识别容易患抑郁症的患者.
- 进一步的纵向研究是有必要的,以探索这些发现.
相关概念视频
Depression: Overview
1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K
Depressive Disorders: Etiology
827
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
827
Depressive Disorders: MDD and Dysthymia
1.0K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.0K
Long-term Depression
3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.5K
Long-term Depression
33.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.6K
Antidepressant Drugs: Overview
1.9K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.9K


